AIMS: Depression is common in diabetes, but little is known about depression in minorities with diabetes. This study investigated (1) racial/ethnic variation in depressive symptoms, (2) racial/ethnic variation in patient-reported physician-diagnosed depression, (3) racial/ethnic variation in patient-reported pharmacological depression treatment, and (4) the effects of demographic and diabetes variables on these outcomes. PARTICIPANTS: A community sample of 740 persons with diabetes attending diabetes health fairs in the northeastern US participated. DESIGN: Cross-sectional, observational. Participants were paid $5 on-site for completing a one-time, anonymous self-report questionnaire. MEASUREMENTS: The questionnaire asked about demographics and diabetes, as well as physician-diagnosed depression and medication for depression. The Center for Epidemiological Studies Depression scale was used to determine depressive symptoms. RESULTS: ANCOVA revealed that rates of depressive symptoms were similar among White, African-American, and Latino persons with diabetes. One quarter (24.2%) endorsed physician-diagnosed depression, and 40.2% of them (9.7% of the total sample) reported pharmacological treatment. In logistic regression, African-Americans reported lower rates of physician-diagnosed depression than Whites, OR=0.470. In logistic regression, those African Americans who endorsed depression diagnosis reported marginally lower rates of pharmacotherapy than Whites, OR=0.415. CONCLUSIONS: Providers are encouraged to address depression in their diabetic patients, paying particular attention to minorities.
AIMS: Depression is common in diabetes, but little is known about depression in minorities with diabetes. This study investigated (1) racial/ethnic variation in depressive symptoms, (2) racial/ethnic variation in patient-reported physician-diagnosed depression, (3) racial/ethnic variation in patient-reported pharmacological depression treatment, and (4) the effects of demographic and diabetes variables on these outcomes. PARTICIPANTS: A community sample of 740 persons with diabetes attending diabetes health fairs in the northeastern US participated. DESIGN: Cross-sectional, observational. Participants were paid $5 on-site for completing a one-time, anonymous self-report questionnaire. MEASUREMENTS: The questionnaire asked about demographics and diabetes, as well as physician-diagnosed depression and medication for depression. The Center for Epidemiological Studies Depression scale was used to determine depressive symptoms. RESULTS: ANCOVA revealed that rates of depressive symptoms were similar among White, African-American, and Latino persons with diabetes. One quarter (24.2%) endorsed physician-diagnosed depression, and 40.2% of them (9.7% of the total sample) reported pharmacological treatment. In logistic regression, African-Americans reported lower rates of physician-diagnosed depression than Whites, OR=0.470. In logistic regression, those African Americans who endorsed depression diagnosis reported marginally lower rates of pharmacotherapy than Whites, OR=0.415. CONCLUSIONS: Providers are encouraged to address depression in their diabeticpatients, paying particular attention to minorities.
Authors: Sherita Hill Golden; Arleen Brown; Jane A Cauley; Marshall H Chin; Tiffany L Gary-Webb; Catherine Kim; Julie Ann Sosa; Anne E Sumner; Blair Anton Journal: J Clin Endocrinol Metab Date: 2012-06-22 Impact factor: 5.958
Authors: Chandra Y Osborn; Hollister W Trott; Maciej S Buchowski; Kushal A Patel; Leslie D Kirby; Margaret K Hargreaves; William J Blot; Sarah S Cohen; David G Schlundt Journal: Diabetes Care Date: 2010-02-25 Impact factor: 19.112
Authors: Julie A Wagner; Denise White Perkins; John D Piette; Bonnie Lipton; James E Aikens Journal: Diabetes Res Clin Pract Date: 2009-09-19 Impact factor: 5.602